(Q45756781)

English

A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus

scientific article published in March 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus (English)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kline MW

1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

Fletcher CV

2

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

Harris AT

3

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

Evans KD

4

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

Brundage RC

5

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

Remmel RP

6

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

Calles NR

7

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

Kirkpatrick SB

8

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

Simon C

9

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

The Journal of Pediatrics

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

132

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

3 Pt 1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

543-546

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir).

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970039-3

7 January 2021

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970039-3

7 January 2021

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970039-3

7 January 2021

Indinavir nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970039-3

7 January 2021

Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970039-3

7 January 2021

Identifiers

10.1016/S0022-3476(98)70039-3

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/9544920

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45756781&oldid=2081059700"